Synthesis and Biological Evaluation of Fluorine-18 and Deuterium Labeled l-Fluoroalanines as Positron Emission Tomography Imaging Agents for Cancer Detection. [PDF]
Li K +8 more
europepmc +1 more source
An explainable CatBoost model was trained to predict the bandgaps of 474 phosphate crystals based on composition and density descriptors. SHAP analysis identified two key variables—d‐electron‐count dispersion and atomic‐density dispersion—as the primary drivers of the model's predictions.
Wenhu Wang +3 more
wiley +1 more source
Fluorine-18 FDG PET/CT and New NIMS Grading System for Chemotherapy Response in Breast Cancer. [PDF]
Vakati GR, Ratnagiri R, Srivastava MK.
europepmc +1 more source
In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18-Labeled THK5351.
Kim M +13 more
europepmc +1 more source
Multimodal radiomics based on fluorine-18 prostate-specific membrane antigen positron emission tomography and multiparametric magnetic resonance imaging in predicting persistent prostate-specific antigen after radical prostatectomy. [PDF]
Yuan Y +11 more
europepmc +1 more source
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography revealed the course of granulocyte-colony stimulating factor-associated aortitis: A case report. [PDF]
Hijikata Y +7 more
europepmc +1 more source
Related searches:
Production of reactive fluorine-18
International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986Production conditions are reviewed from the perspective of maximizing activity--both total and specific--of 18F as electrophilic or nucleophilic precursors, with minimal levels of interfering species. Careful target design can avoid many pitfalls, and telemetry of a few key variables can guide the way to reproducible yields, consistent with prediction.
R J, Nickles +3 more
openaire +2 more sources
The Preparation of Fluorine-18 Labelled Radiopharmaceuticals
The International Journal of Applied Radiation and Isotopes, 1977Abstract Progress in the preparation of fluorine-18 labelled radiopharmaceuticals is reviewed. The pharmacology and design of 18F-labelled organic compounds of biomedical interest, production of the radionuclide and methods of labelling which have been used to date are discussed. Emphasis has been placed on the practical chemical problems encountered,
A K, Horsch +3 more
openaire +2 more sources

